Bloomage, also known as Bloomage Biotech, is a biomaterial company based in China. 688363. Shanghai Stock Exchange. Bloomage Biotechnology. Yahoo. Bloomage primarily specializes in hyaluronic acid and other bioactive substances products. It is listed on the Shanghai Stock Exchange. Wall Street Journal.
Bloomage's first plant in Jinan was completed and put into production in 2005.
Bloomage was licensed by the US FDA and established a US subsidiary in 2012. GRAS Notice No. GRN 00097. US Food and Drug Administration. NASDAQ 2017 annual report.
Other than hyaluronic acid, Bloomage also manufactures recombinant collagen, ergothioneine, ectoine, GABA, PDRN, among others. The company also produces skin fillers and various cosmetic products. Beauty and the East: China’s Plastic Surgery Boom. Feb. 4, 2016. The Wall Street Journal.
|
|